Assessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: study protocol for a randomised controlled trial (OPTIM-PTL Study).

dc.contributor.author
Cobo, Teresa
dc.contributor.author
Aldecoa, Victoria
dc.contributor.author
Bartha, José Luis
dc.contributor.author
Bugatto, Fernando
dc.contributor.author
Carrillo Badillo, María Paz
dc.contributor.author
Comas, Carmina
dc.contributor.author
Diago Almeda, Vicente
dc.contributor.author
Ferrero, Silvia
dc.contributor.author
Goya, Maria
dc.contributor.author
Herraiz, Ignacio
dc.contributor.author
Martí Malgosa, Laia
dc.contributor.author
Olivella, Anna
dc.contributor.author
Paules, Cristina
dc.contributor.author
Ferrero, Silvia
dc.contributor.author
Figueras Retuerta, Francesc
dc.contributor.author
Palacio, Montse
dc.contributor.author
Gratacós Solsona, Eduard
dc.contributor.author
OPTIM-PTL group
dc.date.issued
2023-03-29T14:28:04Z
dc.date.issued
2023-03-29T14:28:04Z
dc.date.issued
2021-09-28
dc.date.issued
2023-03-29T14:28:04Z
dc.identifier
2044-6055
dc.identifier
https://hdl.handle.net/2445/196209
dc.identifier
721654
dc.identifier
34588268
dc.description.abstract
Introduction: The majority of women admitted with threatened preterm labour (PTL) do not delivery prematurely. While those with microbial invasion of the amniotic cavity (MIAC) represent the highest risk group, this is a condition that is not routinely ruled out since it requires amniocentesis. Identification of low-risk or high-risk cases might allow individualisation of care, that is, reducing overtreatment with corticosteroids and shorten hospital stay in low-risk women, while allowing early antibiotic therapy in those with MIAC. Benefits versus risks of amniocentesis-based predictor models of spontaneous delivery within 7 days and/or MIAC have not been evaluated. Methods and analysis: This will be a Spanish randomised, multicentre clinical trial in singleton pregnancies (23.0-34.6 weeks) with PTL, conducted in 13 tertiary centres. The intervention arm will consist in the use of amniocentesis-based predictor models: if low risk, hospital discharge within 24 hours of results with no further medication will be recommended. If high risk, antibiotics will be added to standard management. The control group will be managed according to standard institutional protocols, without performing amniocentesis for this indication. The primary outcome will be total antenatal doses of corticosteroids, and secondary outcomes will be days of maternal stay and the occurrence of clinical chorioamnionitis. A cost analysis will be undertaken. To observe a reduction from 90% to 70% in corticosteroid doses, a reduction in 1 day of hospital stay (SD of 2) and a reduction from 24% to 12% of clinical chorioamnionitis, a total of 340 eligible patients randomised 1 to 1 to each study arm is required (power of 80%, with type I error α=0.05 and two-sided test, considering a dropout rate of 20%). Randomisation will be stratified by gestational age and centre.
dc.format
6 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
BMJ Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1136/bmjopen-2021-054711
dc.relation
BMJ Open, 2021, vol. 11, num. 9, p. e054711
dc.relation
https://doi.org/10.1136/bmjopen-2021-054711
dc.rights
cc-by-nc (c) Cobo, Teresa et al., 2021
dc.rights
https://creativecommons.org/licenses/by-nc/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject
Part prematur
dc.subject
Avaluació del risc per la salut
dc.subject
Líquid amniòtic
dc.subject
Infeccions
dc.subject
Serveis de salut maternal
dc.subject
Corticosteroides
dc.subject
Ecografia
dc.subject
Premature labor
dc.subject
Health risk assessment
dc.subject
Amniotic liquid
dc.subject
Infections
dc.subject
Maternal health services
dc.subject
Adrenocortical hormones
dc.subject
Ultrasonic imaging
dc.title
Assessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: study protocol for a randomised controlled trial (OPTIM-PTL Study).
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)